47 Followers on Owler
OverviewCompetitorsFundingNews & Insights

G1 Therapeutics Competitors or Alternatives

G1 Therapeutics's top competitors include Kite Pharma, Perthera and bluebird bio.

Unlock 10 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

G1 Therapeutics's company profile

Jack Bailey

CEO

84/100
170
$349.4M
$58.2M
  • $349.4M
    $58.2M
  • 170
    $349.4M
  • $58.2M
  • 84/100
  • 170
  • $349.4M
  • $58.2M
View ProfileView
1
G1 Therapeutics's Competitor - Kite Pharma logo

CEO

- -
1,000 - 5,000
$634.9M
$25M - 100M
  • $634.9M
    $25M - 100M
  • 1,000 - 5,000
    $634.9M
  • $25M - 100M
  • - -
  • 1,000 - 5,000
  • $634.9M
  • $25M - 100M
View ProfileView
2
G1 Therapeutics's Competitor - Perthera logo

Donna Tuths

President & CEO

82/100
25 - 100
$17.9M
$100K - 5M
  • $17.9M
    $100K - 5M
  • 25 - 100
    $17.9M
  • $100K - 5M
  • 82/100
  • 25 - 100
  • $17.9M
  • $100K - 5M
View ProfileView
3
G1 Therapeutics's Competitor - bluebird bio logo

Andrew Obenshain

CEO

73/100
520
$821.4M
$83.8M
  • $821.4M
    $83.8M
  • 520
    $821.4M
  • $83.8M
  • 73/100
  • 520
  • $821.4M
  • $83.8M
View ProfileView
4
G1 Therapeutics's Competitor - Fate Therapeutics logo

Bahram Valamehr

President & CEO

82/100
550
$366.3M
$13.6M
  • $366.3M
    $13.6M
  • 550
    $366.3M
  • $13.6M
  • 82/100
  • 550
  • $366.3M
  • $13.6M
View ProfileView
5
G1 Therapeutics's Competitor - Zyngenia logo

Andrey Kolokoltsov

CEO

- -
1 - 25
$43M
$5M - 25M
  • $43M
    $5M - 25M
  • 1 - 25
    $43M
  • $5M - 25M
  • - -
  • 1 - 25
  • $43M
  • $5M - 25M
View ProfileView
G1 Therapeutics' top 13 competitors are Kite Pharma, Perthera, bluebird bio, Parion Sciences, Fate Therapeutics, Zyngenia, Tenax, Universal Security Instruments, Kadmon, Eurasia Consulting, Pfizer, Juno Therapeutics and Chimerix. Together they have raised over 5.0B between their estimated 87.5K employees. G1 Therapeutics has 170 employees and is ranked 6th among it's top 10 competitors. The top 10 competitors average 6,258.

G1 Therapeutics VS Kite Pharma

Kite Pharma is G1 Therapeutics's #1 competitor. Kite Pharma's headquarters is in Santa Monica, California, and was founded in 2009. Like G1 Therapeutics, Kite Pharma also works within the Biotechnology sector. Kite Pharma generates 77% of G1 Therapeutics's revenue.

G1 Therapeutics VS Perthera

Perthera is one of G1 Therapeutics's top rivals. Perthera was founded in McLean, Virginia} in 2012. Perthera operates in the Pharmaceuticals & Biotech Technology industry. Compared to G1 Therapeutics, Perthera generates $53.9M less revenue.

G1 Therapeutics VS bluebird bio

bluebird bio is one of G1 Therapeutics's top competitors. bluebird bio is a Public company that was founded in 1992 in Somerville, Massachusetts. bluebird bio is in the Biotechnology industry. Compared to G1 Therapeutics, bluebird bio has 350 more employees.

Looking for similar companies to G1 Therapeutics?

Similar Companies

Biotechnology companies in Research Triangle Park

See 12 companies 
Biotechnology companies in Research Triangle

See 235 companies 
Pharmaceuticals & Biotechnology companies in Research Triangle Park

See 13 companies 
Biotechnology companies in North Carolina

See 363 companies 
Pharmaceuticals & Biotechnology companies in Research Triangle

See 408 companies 
Pharmaceuticals & Biotechnology companies in North Carolina

See 641 companies 
Biotechnology companies with revenue in $25-100M range

See 854 companies 
Biotechnology companies with employees in 100-250 range

See 1,110 companies 
Pharmaceuticals & Biotechnology companies with revenue in $25-100M range

See 1,457 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for G1 Therapeutics and G1 Therapeutics's Competitors

April 10, 2025Pharmaceutical Processing World
Novartis announced today that it plans to invest $23 billion over five years to expand its U.S.-based infrastructure. The company said its investment a...
April 10, 2025centralcharts
Pfizer Inc. (NYSE: PFE) announced today that its shareholders and the general public are invited to access its virtual 2025 Annual Meeting of Sharehold...
April 10, 2025Endpoints News
With US tariffs on pharmaceuticals likely to come "very soon," another of the world's largest drugmakers is announcing plans to beef up their American ...

Frequently Asked Questions about G1 Therapeutics

  1. Who are G1 Therapeutics's top competitors?

    G1 Therapeutics's top 3 competitors are Kite Pharma, Perthera, bluebird bio.

  2. Who is similar to G1 Therapeutics?

    Kite Pharma is the most similar to G1 Therapeutics. Perthera and bluebird bio are also similar to G1 Therapeutics.

  1. Are G1 Therapeutics and Kite Pharma competitors?

    Yes, Kite Pharma is one of G1 Therapeutics’s top competitors.